Trio of Factors Behind Falling Heart Disease Mortality
By HospiMedica International staff writers Posted on 16 Mar 2016 |
Changes in smoking prevalence, serum cholesterol, and systolic blood pressure (BP) have been the major reason behind falling coronary heart disease (CHD) mortality over the past 40 years, according to a new study.
Researchers at the Finnish National Institute for Health and Welfare (Helsinki, Finland) conducted a population-based observational study to estimate how changes in the main risk factors of cardiovascular disease (CVD) can explain the reduction in CHD mortality observed among the working age population in eastern Finland. Participants included 34,525 men and women aged 30–59 years of age who participated in national studies between 1972 and 2012. The main outcome measures were predicted and observed age standardized mortality due to CHD.
The results showed that during the 40 years of the study, CHD mortality decreased by 82% and 84% among men and women aged 35–64 years, respectively. During this time, levels of the three major CVD risk factors decreased, except for a small increase in serum cholesterol levels between 2007 and 2012. Since the mid-1980s, the observed reduction in mortality has been larger than predicted, with about two thirds of the reduction explained by changes in the three main risk factors, and the remaining third by other factors. The study was published on March 1, 2016, in BMJ.
“Although secondary prevention and treatment protocols have markedly developed in recent decades, primary prevention and reduction in levels of the main classical factors contributing to cardiovascular risk should still be considered as the main strategy to reduce disease burden and mortality due to coronary heart disease,” concluded lead author Pekka Jousilahti, MD, PhD. “The changes in the three target risk factors during the first ten years of the study contributed to nearly all of the observed mortality reduction.”
Mortality from CHD started to increase in Finland in the 1950s, associated with an increasing standard of living, dietary causes, and other lifestyle changes. In the late 1960s, this mortality was the highest in the world, and was particularly high among working aged men in the eastern part of the country. As a result, the North Karelia Project was launched in 1972, with the aim of reducing the extremely high mortality from CHD by focusing on behavioral change through community action and participation, supported by screening of high risk individuals and medical treatment.
Related Links:
Finnish National Institute for Health and Welfare
Researchers at the Finnish National Institute for Health and Welfare (Helsinki, Finland) conducted a population-based observational study to estimate how changes in the main risk factors of cardiovascular disease (CVD) can explain the reduction in CHD mortality observed among the working age population in eastern Finland. Participants included 34,525 men and women aged 30–59 years of age who participated in national studies between 1972 and 2012. The main outcome measures were predicted and observed age standardized mortality due to CHD.
The results showed that during the 40 years of the study, CHD mortality decreased by 82% and 84% among men and women aged 35–64 years, respectively. During this time, levels of the three major CVD risk factors decreased, except for a small increase in serum cholesterol levels between 2007 and 2012. Since the mid-1980s, the observed reduction in mortality has been larger than predicted, with about two thirds of the reduction explained by changes in the three main risk factors, and the remaining third by other factors. The study was published on March 1, 2016, in BMJ.
“Although secondary prevention and treatment protocols have markedly developed in recent decades, primary prevention and reduction in levels of the main classical factors contributing to cardiovascular risk should still be considered as the main strategy to reduce disease burden and mortality due to coronary heart disease,” concluded lead author Pekka Jousilahti, MD, PhD. “The changes in the three target risk factors during the first ten years of the study contributed to nearly all of the observed mortality reduction.”
Mortality from CHD started to increase in Finland in the 1950s, associated with an increasing standard of living, dietary causes, and other lifestyle changes. In the late 1960s, this mortality was the highest in the world, and was particularly high among working aged men in the eastern part of the country. As a result, the North Karelia Project was launched in 1972, with the aim of reducing the extremely high mortality from CHD by focusing on behavioral change through community action and participation, supported by screening of high risk individuals and medical treatment.
Related Links:
Finnish National Institute for Health and Welfare
Latest Critical Care News
- Monitoring Airborne Fungal Spores Could Help Predict COVID-19 & Flu Surges
- New System Measures Blood Sodium Without Needles
- Sleep Data from Wearable Device May Help Predict Preterm Birth
- AI Tool Interprets Echocardiograms in Minutes
- Electrochemical Catheter Hub Prevents Bloodstream Infections
- Noninvasive Double Microbubble Delivery Approach Marks Breakthrough in Brain Cancer Treatment
- Self-Healing Skin-Like Material to Find Applications in Health Monitoring, Surgery and Implants
- Highly-Sensitive Electronic Skin Allows Robots to Feel Heat, Pain and Pressure
- AI-Powered Wearable Sensor Predicts Labor Onset in Pregnant Women
- Implantable Device to Redefine Continuous Glucose Monitoring
- Smart Microgel Could Repair and Replace Damaged Organs
- Smart Breath Tracker Wristband to Revolutionize Respiratory Care
- Stronger Blood Clot Prevention Measures Needed After Leg Artery Procedures in High-Risk Patients
- AI Tool Catches Missed Illnesses Associated with Inflammatory Bowel Disease
- First Ever Device Diagnoses Life-Threatening Complication Post-Cardiac Surgery
- Contactless Vital Sign Monitoring Device Measures Respiratory Rate Through Smartphones
Channels
Surgical Techniques
view channel
First-Ever Technology Makes Blood Translucent During Surgery
No matter the discipline or scale, bleeding is a regular part of any surgery and can create several challenges. In operating room imaging, seeing through blood in real-time during a surgery has been a... Read more
Tibia Nailing System with Novel Side-Specific Nails to Revolutionize Fracture Surgery
Smith+Nephew (Hull, UK;) has launched its new TRIGEN MAX Tibia Nailing System for stable and unstable fractures of the tibia, including the shaft. It is the only system to now offer trauma surgeons the... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more